Treatment of MC38 tumor–bearing mice with exogenous IL-2 and anti–IL-2 complex (clone S4B6-1), which is known to potently expand CD8+ T cells (32, 44, 45), significantly reduced TOXhi cluster 11 TILs (Supplemental Figure 14, C and E). This evidence concerns the gene IL2 and neoplasm.